当前位置:首页 - 行情中心 - 光正眼科(002524) - 财务分析 - 现金流量表

光正眼科

(002524)

  

流通市值:19.86亿  总市值:20.10亿
流通股本:5.09亿   总股本:5.15亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金386,264,265.76195,720,902.46876,116,209.91630,198,189.58
  收到的税费返还10,960.88--134,798.12
  收到其他与经营活动有关的现金6,292,169.354,727,162.26,140,411.119,192,058.09
  经营活动现金流入小计392,567,395.99200,448,064.66882,256,621.02639,525,045.79
  购买商品、接受劳务支付的现金142,850,778.6867,479,954.26329,818,475.43240,555,349.72
  支付给职工以及为职工支付的现金116,346,790.3257,152,984.96261,470,994.41201,965,405.81
  支付的各项税费27,920,327.9414,841,243.3825,615,007.9320,814,393.6
  支付其他与经营活动有关的现金74,146,817.3253,904,133.18140,626,177.45122,484,349.77
  经营活动现金流出小计361,264,714.26193,378,315.78757,530,655.22585,819,498.9
  经营活动产生的现金流量净额31,302,681.737,069,748.88124,725,965.853,705,546.89
二、投资活动产生的现金流量:
  收回投资收到的现金225,426225,42612,609,973.7111,508,917.57
  取得投资收益收到的现金--96,198.02-
  处置固定资产、无形资产和其他长期资产收回的现金净额513,081.5132,3621,334,580.4107,176.47
  处置子公司及其他营业单位收到的现金净额20,066,616.66---
  投资活动现金流入小计20,805,124.16357,78814,040,752.1311,616,094.04
  购建固定资产、无形资产和其他长期资产支付的现金4,980,550.172,654,261.6729,039,668.7916,004,841.73
  投资活动现金流出小计4,980,550.172,654,261.6729,039,668.7916,004,841.73
  投资活动产生的现金流量净额15,824,573.99-2,296,473.67-14,998,916.66-4,388,747.69
三、筹资活动产生的现金流量:
  吸收投资收到的现金--400,000400,000
  其中:子公司吸收少数股东投资收到的现金--400,000400,000
  取得借款收到的现金210,900,000101,000,000347,900,000269,900,000
  收到其他与筹资活动有关的现金--10,000,000-
  筹资活动现金流入小计210,900,000101,000,000358,300,000270,300,000
  偿还债务支付的现金213,657,905.5280,940,000362,569,388.04256,809,388.04
  分配股利、利润或偿付利息支付的现金6,386,311.133,197,840.9315,081,193.3711,684,314.84
  支付其他与筹资活动有关的现金41,889,563.7825,780,168.81109,497,230.9776,778,994.52
  筹资活动现金流出小计261,933,780.43109,918,009.74487,147,812.38345,272,697.4
  筹资活动产生的现金流量净额-51,033,780.43-8,918,009.74-128,847,812.38-74,972,697.4
五、现金及现金等价物净增加额-3,906,524.71-4,144,734.53-19,120,763.24-25,655,898.2
  加:期初现金及现金等价物余额44,915,203.0944,915,203.0964,035,966.3364,035,966.33
  期末现金及现金等价物余额41,008,678.3840,770,468.5644,915,203.0938,380,068.13
补充资料:
  净利润17,792,185.18--19,671,149.03-
  资产减值准备-40,687-1,644,534.47-
  固定资产和投资性房地产折旧11,824,769.51-27,484,181.46-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,824,769.51-27,484,181.46-
  无形资产摊销1,261,519.74-4,324,988.3-
  长期待摊费用摊销3,317,922.97-9,625,250.14-
  处置固定资产、无形资产和其他长期资产的损失-1,488,263.24-204,958.49-
  固定资产报废损失6,910.53-74,879.82-
  财务费用15,180,457.94-34,003,376.86-
  投资损失-20,472,729.17--9,411,886.6-
  递延所得税-710,876.84--2,093,594.16-
  其中:递延所得税资产减少-604,593.1--2,054,358.43-
    递延所得税负债增加-106,283.74--39,235.73-
  存货的减少2,624,333.39--1,887,774.29-
  经营性应收项目的减少18,216,773.73--15,491,931.04-
  经营性应付项目的增加-43,128,770.47-40,148,727.11-
  其他-112,975.76--4,560,031.98-
  现金的期末余额41,008,678.38-44,915,203.09-
  减:现金的期初余额44,915,203.09-64,035,966.33-
  现金及现金等价物的净增加额-3,906,524.71--19,120,763.24-
公告日期2026-08-222026-04-282026-04-242025-10-24
审计意见(境内)标准无保留意见
TOP↑